VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,088 | +19.8% | 2,010 | +34.1% | 0.02% | +27.8% |
| Q2 2023 | $45,135 | -82.8% | 1,499 | -79.6% | 0.02% | -84.5% |
| Q1 2023 | $262,250 | +16.4% | 7,348 | -3.5% | 0.12% | +24.7% |
| Q4 2022 | $225,252 | -21.8% | 7,615 | -20.1% | 0.09% | -30.1% |
| Q1 2022 | $288,000 | -34.8% | 9,529 | -29.9% | 0.13% | -37.3% |
| Q1 2021 | $442,000 | -54.9% | 13,591 | -50.1% | 0.21% | -57.1% |
| Q4 2020 | $981,000 | +152.8% | 27,230 | +175.0% | 0.49% | +195.8% |
| Q3 2020 | $388,000 | -3.7% | 9,901 | +2.7% | 0.17% | +2.5% |
| Q2 2020 | $403,000 | +65.8% | 9,637 | -8.6% | 0.16% | +43.0% |
| Q1 2020 | $243,000 | -30.6% | 10,543 | -11.8% | 0.11% | -21.4% |
| Q4 2019 | $350,000 | +20.3% | 11,949 | +14.4% | 0.14% | +81.2% |
| Q3 2019 | $291,000 | +9.0% | 10,449 | 0.0% | 0.08% | +3.9% |
| Q2 2019 | $267,000 | -7.9% | 10,449 | -19.2% | 0.08% | -4.9% |
| Q1 2019 | $290,000 | -30.0% | 12,938 | -34.1% | 0.08% | -39.6% |
| Q4 2018 | $414,000 | – | 19,646 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |